GRST · As filed with the SEC

Ethema Health income statement, by fiscal year

The statement as Ethema Health presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF OPERATIONS · USD, except per-share amounts

USD, except per-share amounts	FY2025 Year ended Dec 31, 2025	FY2024 Year ended Dec 31, 2024	FY2023 Year ended Dec 31, 2023	FY2022 Year ended Dec 31, 2022	FY2021 Year ended Dec 31, 2021	FY2020 Year ended Dec 31, 2020	FY2019 Year ended Dec 31, 2019	Year ended Dec 31, 2018 Year ended Dec 31, 2018
Revenue	18,764,817	6,017,204	5,344,976	4,820,747	1,942,588	338,996	359,947	432,515
Operating expenses
Selling, General and Administrative Expense	3,934,900	1,550,799	1,041,501	805,372	531,391	55,756	909,613	664,782
Occupancy and Rent Expense	—	—	—	—	—	5,512	1,360,117	731,818
Management fees	—	—	—	—	—	—	—	182,430
Rent expense	—	—	—	—	178,679	—	—	—
Rent expense	—	—	—	427,482	—	—	—	—
Rent expense	—	—	614,793	—	—	—	—	—
Total Operating Expenses	—	—	368,003	132,500	60,000	—	—	—
Professional fees	—	—	—	463,678	—	—	—	—
Rent expense	3,013,306	1,304,127	—	—	—	—	—	—
Management fees	120,000	—	—	—	—	—	—	—
Professional Fees	1,597,072	955,801	707,413	—	132,275	231,264	550,624	510,722
Labor and Employee Benefits	—	—	—	—	—	88,532	1,279,796	953,434
Depreciation Expense	—	—	—	—	—	121,276	217,018	273,646
Impairment expense	—	—	—	—	—	—	242,514	—
Total operating expenses	—	—	—	—	—	502,340	4,559,682	3,316,832
Labor and Employee Benefits	9,547,395	3,072,654	2,656,267	1,962,479	712,787	—	—	—
Depreciation Expense	812,279	466,952	498,919	540,119	325,351	—	—	—
Total operating expenses	19,024,952	7,350,333	5,886,896	4,331,630	1,940,483	—	—	—
Operating loss	(260,135)	(1,333,129)	(541,920)	489,117	2,105	(163,344)	(4,199,735)	(2,884,317)
Other (expense) income
Other Income	—	—	—	—	—	1,183	6,600	6,009
Other expense	—	—	—	—	—	—	—	(8,000)
Non-Operating Income (Expense)	—	—	—	—	—	—	(1,019,812)	—
Non-Operating Income (Expense)	—	—	—	15,760	273,373	—	—	—
Forgiveness of government relief loan	—	—	—	104,368	156,782	—	—	—
Loss on advance	—	—	—	—	(120,000)	—	—	—
Fair value of warrants granted to convertible note holders	—	—	—	—	(854,140)	—	—	—
Penalty on notes and convertible notes	—	—	—	(60,075)	(9,240)	—	—	—
Non-Operating Income (Expense)	—	—	2,484,172	—	—	—	—	—
Non-Operating Income (Expense)	66,107	110,000	—	—	—	—	—	—
Other expense	—	(1,160)	—	—	—	—	—	—
Interest Expense	—	—	(277,175)	—	—	12,601,823	—	—
Profit (loss) on sale of assets	—	—	—	—	—	36,470	—	—
Warrants exercised	—	—	—	—	—	(95,868)	—	—
Penalty on convertible notes	—	—	—	—	—	—	(569,628)	—
Loss on conversion of convertible debentures	—	—	—	—	—	(585,351)	(203,981)	—
Deposit forfeited	—	—	—	—	—	—	(1,665,078)	—
Total Interest Income	—	—	—	—	—	629	17,226	5,334
Interest expense	—	—	—	—	—	(631,425)	(1,079,038)	(696,944)
Debt discount	—	—	—	—	—	(861,657)	(3,338,760)	(4,504,007)
Derivative liability movement	—	—	—	—	—	(7,041,968)	(2,599,029)	(422,539)
Foreign exchange movements	—	—	—	—	—	(175,500)	(311,606)	428,053
Net income (loss) before taxation	—	—	—	—	—	3,084,992	(14,962,841)	(8,076,411)
Taxation	—	—	—	—	—	—	—	(102,232)
Extension fee on property purchase	—	—	(140,000)	—	—	—	—	—
Penalty on notes and convertible notes	—	—	(34,688)	—	—	—	—	—
Interest Income	3,884	2,292	676	78	—	—	—	—
Net Interest Income	—	—	—	—	(829,525)	—	—	—
Interest expense	(1,388,074)	(565,343)	(500,226)	(588,477)	—	—	—	—
Amortization of debt discount	(616,072)	(416,120)	(281,354)	(624,683)	(1,965,551)	—	—	—
Derivative liability movement	—	—	—	—	1,526,191	—	—	—
Foreign exchange movements	—	—	(95,032)	1,071,320	(34,301)	—	—	—
Foreign exchange movements	(36,023)	37,523	—	—	—	—	—	—
Net loss before income taxes	(2,230,313)	(2,165,937)	614,453	407,408	(1,854,306)	—	—	—
Income taxes	52,644	—	391,962	(112,220)	280,903	—	—	—
Net (loss) income	—	(2,165,937)	1,006,415	295,188	—	—	—	—
Profit or Loss	(2,177,669)	—	—	—	(1,573,403)	—	—	—
Net loss attributable to non-controlling stockholders interest	—	101,842	170,184	(47,308)	30,457	—	—	—
Net income attributable to Ethema Health Corporation Stockholders’	—	—	1,176,599	—	—	—	—	—
Net (loss) income attributable to Ethema Health Corporation Stockholders’	—	(2,064,095)	—	—	—	—	—	—
Preferred stock dividend	—	—	(47,225)	(97,782)	(100,584)	—	—	—
Net (loss) income available to common stockholders of Ethema Health Corporation	—	(2,064,095)	1,129,374	150,098	(1,643,530)	3,032,104	—	—
Non-Operating Income (Expense)	—	—	—	—	—	78,743	97,565	(166,042)
Foreign currency translation adjustment	—	—	—	(821,597)	9,813	—	—	—
Total comprehensive income (loss)	—	—	1,129,374	(671,499)	(1,633,717)	3,110,847	(14,865,276)	(8,344,685)
Basic and diluted loss per common share	—	—	—	—	—	0.00	(0.11)	(0.07)
Weighted Average Shares Outstanding, Diluted	—	—	—	—	—	—	136,165,798	123,852,105
Basic income per common share	—	—	0.00	0.00	0.00	—	—	—
Diluted income (loss) per common share	—	—	—	0.00	0.00	—	—	—
Diluted income per common share	—	—	0.00	—	—	—	—	—
Weighted average common shares outstanding – Basic	—	—	3,729,053,805	3,704,807,230	2,701,590,443	—	—	—
Weighted average common shares outstanding – Diluted	—	—	3,903,671,684	4,276,363,181	2,701,590,443	—	—	—
Net loss available to common stockholders of Ethema Health Corporation	(2,177,669)	—	—	247,880	(1,542,946)	3,084,992	(14,962,841)	(8,178,643)
Preferred Dividends	—	—	—	—	—	(52,888)	—	—
Earnings Per Share (Basic)	0.00	0.00	—	—	—	—	—	—
Earnings Per Share (Diluted)	0.00	0.00	—	—	—	—	—	—
Weighted Average Shares Outstanding	—	5,608,835,226	—	—	—	1,594,016,327	—	—
Weighted Average Shares Outstanding, Diluted	—	5,608,835,226	—	—	—	2,045,373,732	—	—

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.